Rinostop nasal spray. dosage. 0.05% fl. 15ml # 1
Dosage:
0.05% x 15ml
0.1% x 15ml
Category
Runny nose
Scope of the medicinal product
Ear, Throat, Nose
Release form
Spray
Manufacturer country
Russia
Package quantity, pcs
one
Latin name
Rinostop
Release form
Nasal spray
Packaging
Bottle 15 ml.
pharmachologic effect
Rinostop is a vasoconstrictor for topical use in ENT practice.
Alpha adrenergic agonist.
When applied to mucous membranes, it causes vasoconstriction, as a result of which local hyperemia and edema decrease.
With rhinitis, it facilitates nasal breathing.
Pharmacokinetics
When applied topically, it is practically not absorbed, plasma concentrations are so small that they cannot be determined by modern analytical methods.
Indications
Acute allergic rhinitis, sinusitis, hay fever, otitis media (to reduce swelling of the nasopharyngeal mucosa), preparing the patient for diagnostic procedures in the nasal passages.
Contraindications
Angle-closure glaucoma, atrophic rhinitis, arterial hypertension, tachycardia, severe atherosclerosis, hyperthyroidism, surgery on the meninges (in history), hypersensitivity to xylometazoline.
Application during pregnancy and lactation
During pregnancy and lactation, it should be used only after a careful assessment of the risk-benefit ratio for the mother and the fetus, it is not allowed to exceed the recommended doses.
Structure
1 ml spray contains:
Active substance: xylometazoline.
Method of administration and dosage
Intranasally.
Spraying is performed after removing the safety cap from the sprayer.
The nebulizer is inserted into the nose and, by pressing on its base, spray for 1 second.
For adults and children over the age of 6 years (0.1% spray): one injection from a nebulizer into each nasal passage, usually 3-4 injections per day are enough
should not be applied more than 3 times a day.
For children aged 2 to 6 years (0.05% spray), one spray from a nebulizer into each nasal passage 1 or 2 times a day
should not be applied more than 3 times a day.
Do not use the drug without interruption for more than 3-5 days.
Side effects
With frequent and / or prolonged use: mucosal irritation, burning, tingling, sneezing, dry nasal mucosa, hypersecretion.
Rarely: swelling of the nasal mucosa (more often with prolonged use), palpitations, cardiac arrhythmias, increased blood pressure, headache, vomiting, sleep disorders, visual disturbances.
With long-term use in high doses: depressive state.
Storage conditions
In a dry, dark place at a temperature not exceeding 25 ° C.
Shelf life
3 years
Dosage
0.05% x 15ml
Structure
1 ml spray contains: Active substance: xylometazoline.
Indications
acute respiratory diseases with symptoms of rhinitis (rhinitis)
acute allergic rhinitis
sinusitis
otitis media (as part of combination therapy to reduce swelling of the nasopharyngeal mucosa)
preparation of the patient for diagnostic manipulations in the nasal passages.
INN / Active ingredient
Xylometazoline
Storage conditions and periods
At a temperature not higher than 25 degrees.
Expiration date: 2 years
Contraindications
arterial hypertension
tachycardia
severe atherosclerosis
glaucoma
atrophic rhinitis
surgical interventions on the meninges (in history)
condition after transsphenoidal hypophysectomy
pregnancy
children under 2 years of age (for Rinostop 0.05%)
children under 6 years of age (for the drug Rinostop 0.1%)
hypersensitivity to xylometazoline and other components of the drug.
The drug should be prescribed with caution in diabetes mellitus, hyperthyroidism, pheochromocytoma, diseases of the cardiovascular system (including coronary artery disease), prostatic hyperplasia, during lactation, in patients with hypersensitivity to adrenomimetics, accompanied by insomnia and dizziness.
Specifications
Category
Runny nose
Scope of the medicinal product
Ear, Throat, Nose
Release form
Spray
Manufacturer country
Russia
Package quantity, pcs
one
Scope of application
Virology
Vacation conditions
Without recipe
Volume, ml.
15 ml
Brand name
OTCPharm
Components
activator with protective cap
The amount of the dosage form in the primary package
15 ml
Primary packaging type
Bottle
Type of consumer packaging
Pack of cardboard
Pharmaco-therapeutic group
Decongestant - alpha adrenergic agonist
Anatomical and therapeutic characteristics
R01AA07 Xylometazoline
Dosage form
Nasal spray
The target audience
Children
Expiration date in days
730
Dosage (volume) of the substance in the preparation
0.5 mg
Package weight, g
thirty
Mode of application
:
Intranasal. < br> < br> Spraying is performed after removing the protective cap from the nebulizer. < br> < br> The nebulizer is inserted into the nose and, pressing on its base, spray for 1 second. < br> < br> For adults and children over the age of 6 years (0.1% spray): one injection from a nebulizer into each nasal passage, usually 3-4 injections per day are enough
should not be applied more than 3 times a day. < br> < br> For children aged 2 to 6 years (0.05% spray), one spray from a nebulizer into each nasal passage 1 or 2 times a day
should not be used more than 3 times a day. < br> Do not use the drug without interruption for more than 3-5 days.
Information on technical characteristics, delivery set, country of manufacture